Ascentawits Pharmaceuticals
China - BeijingPharmaceutical
Focus: Ascentawits Pharmaceuticals is a small-molecule focused biotech company headquartered in Beijing, founded in 2021, targeting neurological disorders. Scale and market position remain unclear due to limited public data.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Ascentawits Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Ascentawits Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AST-001
Solid TumorClinical Trials (1)
NCT06245330A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
Phase 1/2Help build intelligence for Ascentawits Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.